Biosensors that measure glucose are now available without a prescription. Wearing one burst my wellness bubble in ways I wasn ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...

SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.

The results highlight the viability and benefits of a standardized CGM policy in enhancing inpatient diabetes management. Among the 27 nurses who completed the user experience surveys, 74% found ...

Dexcom unveiled its Dexcom G7 continuous glucose monitoring (CGM) for people with diabetes age two years and older in ...

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

DexCom ( DXCM -2.62%) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs ...